Site Selection in Oncology Clinical Trials: Considerations for Selecting Sites in Limited Geographic Regions or Areas of Political Unrest, Limiting Inspection Capabilities (U13) Clinical Trial not allowed.
Department of Health and Human Services Food and Drug Administration
Posted on:
Application Deadline:
Expired
Type
Research/project funding
Reference Number
RFA-FD-23-007
The purpose of this FOA is to support a series of conferences and workshops developed with substantial FDA input to explore challenges regarding site selection of clinical trials sites in studies that are submitted to FDA for regulatory approval of oncology indications.
Categories: Consumer Protection, Science and Technology and other Research and Development.
Categories: Consumer Protection, Science and Technology and other Research and Development.
United States
